Loading...
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
With rates of obesity and diabetes rising across the world, effective therapies to treat hyperglycemia and its associated comorbidities continue to be in demand. Empagliflozin is a highly selective sodium glucose transporter-2 inhibitor that improves serum glucose levels by inducing glucosuria. Take...
Na minha lista:
| Udgivet i: | Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847607/ https://ncbi.nlm.nih.gov/pubmed/27186083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S77754 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|